are required. The method is a modification of a simplified, rapid, and accurate procedure, which is commercially available as a kit. There is excellent correlation between results by these two methods, in which lyophilized digoxin standards and insoluble antibody polymer are used. The digoxin concentration in capillary sera was not significantly different from that in the corresponding venous blood. It is clinically useful to monitor digoxin therapy in capillary sera, particularly in patients in whom blood sampling by venipuncture is inconvenient or difficult. were under treatment for congestive heart failure. They were all maintained with single daily doses of either 0.125 mg (14 patients) or 0.25 mg (26 patients) of digoxin. All blood samples were collected at 1430-1530 hours, 6 h after ingestion of the medication, both by venipuncture of the antecubital vein and by finger prick.
Linear regression analysis was performed to test the precision ofthe original methodology and paired t-tests were used to determine differences between groups (6).
Procedure
The accuracy of these kits was first tested by determining the recovery of digoxin (USP grade) added to digoxin-free sera. These were primary standards and corresponded to 0, 1.2, 2.4, 4.0, and 4.8 ig of digoxin per liter. Assays were conducted according to the procedure prescribed for these kits, which contain secondary standards.
In this study we analyzed 50-id aliquots of venous sera according to the method included with these kits and lO-l aliquota of the same samples according to our modification of this method. We also analyzed samples of both capillary and venous sera from the same patients, collected within 1 mm of one another and the sera frozen if not immediately assayed. After the final washing, the test tubes were inverted, to drain. Each test tube was then washed thoroughly on the outside, rinsed with distilled water, dried, and the radioacactivity of its contents counted.
Results
A line of regression was plotted from the data (Table 1) The method is linear and satisfactorily accurate.
Standard curves were constructed for each assay ( Figure  1 ). During the course of this study, four curves were obtained for each kit, and excellent reproducibility was obtained between them. The same control serum was used as an unknown in each assay. 
Discussion
Our data confirm that the original radioimmunoassay kit for digoxmn gives rapid, accurate results and is suitable for routine clinical use. Because special equipment and preparation of solutions required by other methods is obviated, there are fewer possible sources of laboratory error and less time is required to perform these assays. The simplification of radioimmunoassay of digoxmn when 1251-labeled digoxin is used has been confirmed by others (6, 7).
Our micro-radioimmunoassay for digoxin depends on the specific activity of '251-labeled digoxin supplied by the manufacturer being about 1 mCi/liter or greater, so that the 10-,d volumes we used in this method can be easily detected with a gamma counter.
Our micro-method was compared to the manufacturer's prescribed method.
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There was no significant difference between capillary and venous blood concentration of digoxin.
Therefore, from the practical clinical aspect, our procedure, which requires 10 l rather than 50 l aliquots of sera, can be used when venipuncture is difficult or undesirable, as in cases of extreme obesity, venous thrombosis, or peripheral vascular disease, or for infants and children.
